Atara Biotherapeutics Short Interest Ratio and Short Volume

Short interest is the volume of Atara Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of February 12th, traders have sold 11,740,000 shares of ATRA short.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Atara Biotherapeutics currently has a short interest ratio of 12.0.

Atara Biotherapeutics saw a decrease in short interest in February. As of February 12th, there was short interest totaling 11,740,000 shares, a decrease of 0.7% from the previous total of 11,820,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Atara Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Atara Biotherapeutics: Beam Therapeutics Inc. (16.38%), Allogene Therapeutics, Inc. (15.84%), China Biologic Products Holdings, Inc. (5.58%), SpringWorks Therapeutics, Inc. (9.00%), Relay Therapeutics, Inc. (11.86%), NantKwest, Inc. (15.59%), NanoString Technologies, Inc. (0.00%), Revolution Medicines, Inc. (11.25%), Editas Medicine, Inc. (0.00%), and Sorrento Therapeutics, Inc. (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

Short selling ATRA is an investing strategy that aims to generate trading profit from Atara Biotherapeutics as its price is falling. Atara Biotherapeutics' stock is trading up $0.50 today. To short Atara Biotherapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Atara Biotherapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Atara Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATRA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATRA, twice per month. The most recent reporting period available is February, 12 2021.